GlassScriptPhysician profile
Andrea J Deleo
NPI 1265436042
$51,334.52
in general payments reported to CMS, 2019-2025
60 companies · $1,528 in 2025
The $1,528 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $7,503 · 2021: $4,137 · 2022: $4,146 · 2023: $1,724 · 2024: $2,206 · 2025: $1,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,457.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $26,711.98 | 2019-2023 | Inbrija, Ampyra |
| Abbvie INC. | $10,661.95 | 2019-2025 | Ubrelvy, Duopa, Botox |
| Amgen INC. | $2,112.02 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $1,739.16 | 2019-2025 | Nuplazid |
| Amneal Pharmaceuticals LLC | $1,123.57 | 2019-2025 | Crexont, Rytary, Lyvispah |
| Kyowa Kirin, INC. | $1,120.49 | 2020-2023 | Nourianz |
| Abbott Laboratories | $686.27 | 2019-2023 | Infinity |
| Jazz Pharmaceuticals INC. | $653.56 | 2019-2025 | |
| Biogen, INC. | $598.28 | 2022-2025 | Vumerity, Tysabri, Avonex |
| Avadel Cns Pharmaceuticals, LLC | $504.87 | 2023-2025 | Lumryz |
| Neurocrine Biosciences, INC. | $480.10 | 2019-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $390.15 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $303.05 | 2019-2024 | Austedo Xr, Austedo |
| Lundbeck LLC | $289.52 | 2019-2024 | Vyepti |
| Mdd US Operations, LLC | $255.07 | 2019-2025 | Apokyn |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Deleo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.